等待开盘 02-07 09:30:00 美东时间
+6.095
+0.80%
The earnings results for Regeneron Pharmaceuticals (NASDAQ:REGN) for Q4 were ma...
01-30 21:48
Regeneron Pharmaceuticals (NASDAQ:REGN) will release its quarterly earnings rep...
01-29 22:01
Earnings season is in full-swing with reports this week from several Mag Seven names, big tech companies, defense primes, telecoms and more.
01-26 21:20
Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment?
01-08 05:18
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
2025-12-18 23:14
Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.
2025-12-08 22:54
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
2025-11-26 02:30
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.
2025-11-21 01:43
Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, among others.
2025-11-04 07:17
美股周三早盘,标普500指数成份股再生元制药公司(Regeneron,REGN)股价上涨6.7%,该公司正见证其核心产品的收入增长,目前这一增长已抵消了其先前重磅药物收入的下降。分析师称再生元值得买入。 海量资讯、精准解读,尽在新浪财经APP 责任编辑:张俊 SF065
2025-10-01 22:25